IMPURITIES AVAILABLE FOR 'Regorafenib'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Regorafenib. Regorafenib is an oral multikinase inhibitor used primarily in the treatment of metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma. It blocks multiple protein kinases involved in tumor angiogenesis, oncogenesis, and the tumor microenvironment, including VEGFR, PDGFR, KIT, and RET. By inhibiting these pathways, regorafenib helps slow tumor growth and reduce blood supply to cancer cells. The drug is taken once daily in cycles and has a predictable pharmacokinetic profile. Common adverse effects include hand–foot skin reaction, hypertension, fatigue, diarrhea, and hepatotoxicity, requiring regular monitoring. Regorafenib is typically used after failure of standard therapies and provides a modest but clinically meaningful survival benefit in advanced cancers. Buy high quality Regorafenib from Omsynth Lifesciences.